SC 13G/A | 2024-02-13 | Lind Global Fund II LP | REVELATION BIOSCIENCES, INC. | 186,500 | - | EDGAR |
SC 13G | 2024-01-03 | SABBY MANAGEMENT, LLC | REVELATION BIOSCIENCES, INC. | 403,233 | 6.4% | EDGAR |
SC 13G | 2023-02-21 | Lind Global Fund II LP | REVELATION BIOSCIENCES, INC. | 186,500 | - | EDGAR |
SC 13G | 2023-02-21 | INTRACOASTAL CAPITAL, LLC | REVELATION BIOSCIENCES, INC. | 184,981 | 5.0% | EDGAR |
SC 13G | 2023-02-14 | AXA IM Prime Impact Master Fund I SCA SICAV-RAIF | REVELATION BIOSCIENCES, INC. | 1,958,984 | 8.3% | EDGAR |
SC 13G/A | 2023-02-06 | Weiss Asset Management LP | REVELATION BIOSCIENCES, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-01-31 | Linden Capital L.P. | REVELATION BIOSCIENCES, INC. | 669,899 | 2.8% | EDGAR |
SC 13G/A | 2022-08-17 | Meteora Capital, LLC | REVELATION BIOSCIENCES, INC. | 0 | 0.0% | EDGAR |
SC 13G | 2022-03-24 | Meteora Capital, LLC | REVELATION BIOSCIENCES, INC. | 750,000 | 11.4% | EDGAR |
SC 13G/A | 2022-03-10 | Karpus Management, Inc. | REVELATION BIOSCIENCES, INC. | 0 | 0.0% | EDGAR |
SC 13D | 2022-02-15 | TIDMARSH GEORGE F | REVELATION BIOSCIENCES, INC. | 2,013,335 | 14.1% | EDGAR |
SC 13G/A | 2022-02-14 | Karpus Management, Inc. | REVELATION BIOSCIENCES, INC. | 841,120 | 12.8% | EDGAR |
SC 13G/A | 2022-02-14 | GLAZER CAPITAL, LLC | REVELATION BIOSCIENCES, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2022-02-11 | Polar Asset Management Partners Inc. | REVELATION BIOSCIENCES, INC. | 0 | 0.0% | EDGAR |
SC 13G | 2022-02-09 | Weiss Asset Management LP | REVELATION BIOSCIENCES, INC. | 488,290 | 5.4% | EDGAR |
SC 13G/A | 2022-02-04 | Hudson Bay Capital Management LP | REVELATION BIOSCIENCES, INC. | 0 | 0.0% | EDGAR |
SC 13G | 2022-01-20 | Linden Capital L.P. | REVELATION BIOSCIENCES, INC. | 744,661 | 5.4% | EDGAR |
SC 13G/A | 2022-01-11 | Feis Lawrence | Petra Acquisition Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2021-10-12 | GLAZER CAPITAL, LLC | Petra Acquisition Inc. | 404,206 | 5.1% | EDGAR |
SC 13G/A | 2021-10-12 | Feis Lawrence | Petra Acquisition Inc. | 746,539 | 9.3% | EDGAR |